MK-0616 is smashing all competitors for the prevention and treatment of atherosclerosis.
AstraZeneca
Posted inClinical Trials, Metabolism
Dorzagliatin: Drug That Can “Cure” Diabetes
Hua Medicine has figured out how to bring type 2 diabetes mellitus into long-term and sustained remission.
Posted inInfections, New Drugs, Regulatory
Beyfortus: Effective Protection for Infants Against Respiratory Syncytial Virus
One injection of nirsevimab reliably protects newborns against the development of RSV-associated lower respiratory tract infections.
Posted inCOVID-19, Infections, Research
Omicron Treatment: Most Effective Drugs
Efficacy of antivirals and monoclonal antibodies for outpatient treatment of COVID-19 infection with the Omicron variant of SARS-CoV-2 coronavirus.
Posted inClinical Trials, In the Pipeline, Metabolism
Most Effective Weight Loss Drugs: Present and Future
Modern pharmacological ways to combat obesity.
Posted inCOVID-19, Infections, New Drugs, Regulatory
Evusheld: First Drug for Strong and Long-Lasting Protection Against Coronavirus
One dose of AstraZeneca’s monoclonal antibody cocktail protects against COVID-19 for six months or longer.
Posted inMetabolism, New Drugs, Regulatory
Mounjaro: New Dual-Action Drug for Type 2 Diabetes Mellitus
Tirzepatide by Eli Lilly is a powerful new antidiabetic drug.